Oppenheimer & Co’s Allergan Inc AGN Stock Holding History

Oppenheimer & Co’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-32,228	Closed	-$6.85M	–	1616
2014 Q4	$6.85M	Buy	32,228 +5,011	+18%	+$996K	0.2%	123
2014 Q3	$4.85M	Sell	27,217 -17,709	-39%	-$2.94M	0.14%	165
2014 Q2	$7.6M	Sell	44,926 -4,248	-9%	-$661K	0.23%	108
2014 Q1	$6.1M	Sell	49,174 -1,048	-2%	-$128K	0.18%	135
2013 Q4	$5.58M	Buy	50,222 +3,193	+7%	+$305K	0.18%	143
2013 Q3	$4.25M	Buy	47,029 +18,179	+63%	+$1.63M	0.15%	179
2013 Q2	$2.43M	Buy	+28,850	New	+$2.99M	0.09%	262

Other funds holding AGN

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return

ECM

Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return

HFS

HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Oppenheimer & Co's AGN Position: Q1 2015 in Review

Oppenheimer & Co sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 32,228 shares — an estimated $6.85M sold.

Oppenheimer & Co first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $7.6M in Q2 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

Oppenheimer & Co reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
Oppenheimer & Co sold 32,228 Allergan Inc shares in Q1 2015, an estimated $6.85M.
Oppenheimer & Co first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
Oppenheimer & Co's Allergan Inc position peaked at $7.6M in Q2 2014.
5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Oppenheimer & Co's 13F filing for Q1 2015, filed 8 May 2015.